EP4306049A1 - Dispositif de surveillance automatique de perfusion de médicament avec échantillons temporisés - Google Patents
Dispositif de surveillance automatique de perfusion de médicament avec échantillons temporisés Download PDFInfo
- Publication number
- EP4306049A1 EP4306049A1 EP23184859.9A EP23184859A EP4306049A1 EP 4306049 A1 EP4306049 A1 EP 4306049A1 EP 23184859 A EP23184859 A EP 23184859A EP 4306049 A1 EP4306049 A1 EP 4306049A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- infusion
- blood
- sample collection
- event
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001802 infusion Methods 0.000 title claims abstract description 176
- 239000003814 drug Substances 0.000 title claims description 61
- 229940079593 drug Drugs 0.000 title claims description 60
- 238000012806 monitoring device Methods 0.000 title description 2
- 210000004369 blood Anatomy 0.000 claims abstract description 108
- 239000008280 blood Substances 0.000 claims abstract description 108
- 238000005070 sampling Methods 0.000 claims abstract description 57
- 238000010241 blood sampling Methods 0.000 claims abstract description 26
- 238000004891 communication Methods 0.000 claims abstract description 13
- 239000012530 fluid Substances 0.000 claims description 45
- 238000003860 storage Methods 0.000 claims description 17
- 239000003978 infusion fluid Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 description 29
- 238000012545 processing Methods 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- 230000008569 process Effects 0.000 description 14
- 238000005259 measurement Methods 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 5
- 206010053567 Coagulopathies Diseases 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 229940127219 anticoagulant drug Drugs 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004590 computer program Methods 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000002452 interceptive effect Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 238000012952 Resampling Methods 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 229960003444 immunosuppressant agent Drugs 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000004026 insulin derivative Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000036647 Medication errors Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 241000921645 Ranunculus auricomus Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 206010057362 Underdose Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 244000078885 bloodborne pathogen Species 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000010801 machine learning Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000155 toxicity by organ Toxicity 0.000 description 1
- 230000007675 toxicity by organ Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/15003—Source of blood for venous or arterial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150229—Pumps for assisting the blood sampling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150992—Blood sampling from a fluid line external to a patient, such as a catheter line, combined with an infusion line; blood sampling from indwelling needle sets, e.g. sealable ports, luer couplings, valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/153—Devices specially adapted for taking samples of venous or arterial blood, e.g. with syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/155—Devices specially adapted for continuous or multiple sampling, e.g. at predetermined intervals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
- A61M1/0236—Multiple bag systems for separating or storing blood components with sampling means, e.g. sample bag or sampling port
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/44—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests having means for cooling or heating the devices or media
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
Definitions
- the disclosure relates to a method for use in treating patients and performing biomedical research, and in particular to a method for collecting blood samples or other fluids from patients for diagnostic or research purposes.
- Infusion therapy is a type of treatment which involves infusing fluid or medication (in a solution, for example) via intravenous or subcutaneous injection via a fenestrated catheter attached to an infusion pump.
- a doctor or nurse who is treating a patient using infusion therapy needs to also draw blood samples from the patient at predetermined periods of time, for example, once every morning, to monitor the patient's condition as well as to observe whether the infusion therapy is working properly and there is no serious physiological response (e.g., side effect) to the treatment.
- Infusion therapy has a range of medical applications such as sedation, anesthesia, post-operative analgesic pain management, chemotherapy, and treatment of infectious diseases, and its efficacy due to precise medication delivery is one of its advantages over non-site-specific delivery methodologies.
- An automated blood sampling and infusion system includes: a sampling pump in communication with a blood sample collection apparatus; an infusion pump configured to perform infusion; and a controller configured to: control the infusion pump to perform the infusion on a patient during an infusion event, control the sampling pump to draw blood from the patient into the blood sample collection apparatus during a sample collection event following the infusion event, and automatically store in a memory unit a timestamped data of the infusion event and the sample collection event.
- the timestamped data includes (a) start time of the sample collection event or the infusion event and (b) end time of the sample collection event or the infusion event. In some examples, the timestamped data further includes an amount of blood drawn during the sample collection event or an amount of fluid solution expelled during the infusion event.
- the infusion event includes the type and amount of the fluid solution that is expelled.
- the automated blood sampling and infusion system includes a user interface to input information regarding the sample collection events and the infusion events.
- the blood sample collection apparatus include a plurality of sample containers. Each sample container receives one sample of blood drawn from the patient during one sample collection event, and the sample container is linked to the timestamped data assigned to that sample collection event.
- an amount of blood drawn for the sample ranges from 0.01 cc to 10 cc.
- a user interface facilitates inputting the amount of blood to be drawn for the sample.
- the automated blood sampling and infusion system includes at least one additional electronic device operatively coupled with the controller via a wired or wireless network connection, the at least one additional electronic device to provide information regarding the sample collection event and the infusion event and to receive the timestamped data of every sample collection event and infusion event facilitated by the controller.
- the automated blood sampling and infusion system includes a multi-lumen catheter comprising at least a first lumen and a second lumen, wherein the first lumen is in fluid communication with the infusion solution storage and the second lumen is in fluid communication with the sample collection storage.
- the memory unit stores therein a drug library comprising instructions on the sample collection events and the infusion events associated with each of a plurality of drugs (or fluid solutions) administered during the infusion event.
- the controller is configured to control the sampling pump to perform a plurality of sample collection events associated with a plurality of timestamped data.
- the blood sample collection apparatus includes a cassette removably installed therein and containing a plurality of sample containers, and each of the sample containers contains one sample of the blood drawn from the patient during one of the sample collection events.
- the blood sample collection apparatus is operable to refrigerate the sample containers during the sample collection events.
- an amount of blood drawn for the sample ranges from 0.01 cc to 10 cc.
- a user interface facilitates inputting the amount of blood to be drawn for the sample and a time interval between the sample collection events.
- an automated blood sampling and infusion system includes: a sampling pump in communication with a blood sample collection apparatus containing a plurality of sample containers, each of the sample containers configured to contain one sample of blood drawn from a patient during one of a plurality of sample collection events; an infusion pump configured to perform infusion during a plurality of infusion events; a user interface configured to facilitate inputting an amount of blood to be drawn for each of the samples and a time interval between the sample collection events; and a controller.
- the controller may be configured to: control the infusion pump to perform the infusion on the patient during one of the infusion events; control, based on the amount of blood to be drawn and the time interval that are inputted, the sampling pump to draw the blood from the patient into the blood sample collection apparatus during one of the sample collection events following the infusion event; and automatically store in a memory unit a timestamped data of the infusion event and the sample collection event.
- the amount of blood drawn for the sample ranges from 0.01 cc to 10 cc.
- the method includes: controlling, by a controller, an infusion pump to perform infusion on a patient during an infusion vent; controlling, by the controller, a sampling pump to draw blood from the patient into a blood sample collection apparatus during a sample collection event following the infusion event, and automatically storing, by the controller in a memory unit, a timestamped data of the infusion event and the sample collection event.
- the method further includes determining, by the controller, the condition of the patient based on patient condition measurements received from at least one sensor.
- the timestamped data includes (a) start time of the sample collection event or the infusion event and (b) end time of the sample collection event or the infusion event. In some examples, the timestamped data further includes an amount of blood drawn during the sample collection events or an amount of fluid solution expelled during the infusion events.
- the infusion event includes the type and amount of the fluid solution that is expelled.
- the method includes receiving, by the controller via a user interface, information regarding the sample collection events and the infusion events.
- the blood sample collection apparatus include a plurality of sample containers, and the method further includes configuring, by the controller, each sample container to receive one sample of blood drawn from the patient during the sample collection event; and linking, by the controller, the sample container to the timestamped data assigned to the sample collection event.
- the method includes cooling (or maintaining at an optimal temperature) each of the blood samples (or sample containers/vials) to improve or ensure stability of the collected samples.
- the method further includes receiving, by the controller from at least one additional electronic device operatively coupled with the controller via a wired or wireless network connection, information regarding the sample collection event and the infusion event; and transmitting, by the controller to the at least one additional electronic device, the timestamped data of every sample collection event and infusion event facilitated by the controller.
- the system 100 includes a device 102 for fluid sampling and infusion.
- the fluid that is sampled from the patient as referred to herein is blood, but other types of bodily fluids such as urine or cerebrospinal fluid, for example, may be sampled in some cases.
- the device 102 may be a single device or multiple devices, each with a specific functionality different from the others, that operate together (e.g., in an integrated implementation) for blood sampling or infusion.
- the device 102 is connected to a conduit 104 such as one or more catheters which collect blood samples from the patient and provide drug/fluid solution (such as treatment solution) to the patient's body for infusion.
- drug/fluid solution such as treatment solution
- the device 102 may be sealed to prevent contamination of the fluid inside (whether it is the sample collected or the solution to be used for infusion) from external factors.
- the conduit 104 may be a single-lumen or multi-lumen catheter.
- Prior-art methods as known in the art involve repurposing the original infusion catheter for sampling by manually advancing an inner catheter or internal flow tube through a peripheral intravenous (PIV) line placed through the skin of a patient such that the inner catheter is advanced beyond the tip of the PIV line and into the blood vessel to collect a blood sample. After blood collection, the inner catheter may be manually retracted and removed from the PIV line to be discarded.
- PIV peripheral intravenous
- An example of such method may utilize one or more PIVO TM device from Velano Vascular, a division of Becton, Dickinson and Company.
- a multi-lumen catheter (defined as a catheter having a minimum of two lumens therein, where one lumen is used to introduce the therapeutic fluid and the other lumen is used to withdraw blood from the patient) helps facilitate automatic infusion and blood collection without manual human interaction by doctors or physicians, for example.
- the multi-lumen catheter may have two ports open to the bloodstream, such that a distal (or downstream) port delivers the infusion and a proximal (upstream) port is accessible by the automated blood sampler.
- the vascular access may be configured in this manner to preclude sampling blood immediately downstream from the infusion, before the drug has passed through the circulation, since doing so may provide a sample with an inaccurate drug concentration.
- confusion may be avoided by color-coding the extravascular connectors and/or by using different mechanical connection formats for drug infusion and blood sampling, for example.
- the conduit 104 may be a multi-lumen catheter with at least a first lumen and a second lumen, such that the first lumen is in fluid communication with the infusion solution storage and the second lumen is in fluid communication with the sample collection storage.
- the system 100 includes a controller 106 operatively coupled with the sampling and infusion device 102 or with the subcomponents thereof, as further explained herein.
- the controller 106 controls the operation of the device 102 based on user input or predefined setting.
- the controller 106 may also be capable of making its own decisions, independent of user input, regarding the timing of blood sampling or infusion, or the type, amount, and/or concentration of fluid to be provided for infusion, as further explained herein.
- a network connection 108 may be provided for the controller 106 in some examples such that the controller 106 is operatively connected with a network such as a computer network or digital communications network, as known in the art.
- FIG. 2 shows an example of the controller 106 in some implementations.
- the controller 106 may be a computing device such as a desktop computer, laptop computer, tablet computer, smartphone, or any other suitable device capable of controlling the device 102 for blood sampling and infusion as programmed.
- the controller 106 includes a processing unit 200 which may be a processor such as a general-purpose processor, a special-purpose processor, a conventional processor, a digital signal processor (DSP), a plurality of microprocessors, one or more microprocessors in association with a DSP core, a microcontroller, Application Specific Integrated Circuits (ASICs), Field Programmable Gate Array (FPGAs) circuits, any other type of integrated circuit (IC), a state machine, and the like.
- the processing unit 200 may perform signal coding, data processing, power control, input/output processing, and/or any other functionality that enables the device 102 to operate as intended by the user.
- the controller 106 may be coupled to the device 102 via wire or wirelessly.
- the controller 106 further includes a memory unit 202 which may be any suitable memory, such as non-removable memory such as random-access memory (RAM), read-only memory (ROM), a hard disk, or any other type of memory storage device. Additionally or alternatively, the suitable memory may be removable memory such as a subscriber identity module (SIM) card, a memory stick, a secure digital (SD) memory card, and the like. Additionally or alternatively, the processing unit 200 may access information from, and store data in, memory that is not physically located near the device 102 but is remote, such as on a server or a separately located computer, operatively coupled via the network connection 108.
- the memory unit 202 may be any suitable tangible or non-transitory computer-readable medium capable of storing thereon instructions as one or more computer programs or algorithms, for example, which causes the processing unit 200 to perform certain methods or procedures, as further disclosed herein.
- the controller 106 further includes an input/output interface 204 such as an interactive input/output device including but not limited to a touchscreen display, interactive physical or virtual buttons, and/or microphone/speaker combination, to name a few.
- the interface 204 is configured to receive information from the user as well as to display information to be viewed by the user.
- the collection of blood sample is referred to as a "sample collection event," and the facilitation of infusion in the patient's body is referred to as an "infusion event.”
- the sample collection event and the infusion event may each be determined via user inputs or predetermined settings of the system 100, for example.
- the interface 204 may be a graphical user interface (GUI) displayed on a monitor, a display, or a touchscreen device, for example.
- GUI graphical user interface
- the system 100 may include one or more additional devices 206 which are connected with the controller 106 via the network connection 108 to send data to and/or receive data from the controller 106, for example via a cloud network, Internet, or any other suitable form of digital data communication.
- FIG. 3 shows the components of the device 102 for blood sampling and infusion, according to some implementations.
- the device 102 includes pumps 300 capable of collecting fluid (e.g., blood) for sampling from the patient in an inflow and also providing fluid (e.g., drug solution) for infusion in an outflow.
- fluid e.g., drug solution
- One or more of the pumps may be designed for inflow and/or outflow.
- the pumps may each be assigned a specific role, such as one that is specifically for infusion (infusion pump) and another specifically for sample collection (collection pump or sampling pump).
- the infusion pump may be unidirectional, and the sampling pump may be bidirectional.
- the infusion pump may operate for a longer period of time (for example, at least 1 hour at a time or longer, such as 2 hours or more) and the sampling pump may operate for a shorter period of time (for example, cycling for collection events that each typically lasts about 1 to 5 minutes).
- the device 102 also includes one or more sensors 302 capable of detecting conditions of the patient and/or the blood sample collected from the patient.
- a pressure sensor may be implemented to measure blood pressure of the patient
- a thermometer may be implemented to measure body temperature of the patient, as well as any other suitable sensor known in the art.
- the sensors 302 may also be capable of analyzing the blood sample taken from the patient. For example, after the blood sample is collected, the sensors 302 may automatically measure and analyze the sample to provide a complete blood count (CBC) test, such that any number that is out of the ordinary (e.g., reduced red blood cell count, white blood cell count, platelet count, etc.) may be flagged by the device 102 or by the controller 106 coupled to the device 102, as suitable.
- the sample analysis result is used by the controller 106 to recommend a dosage of the infusion fluid in the next or subsequent infusion event.
- the device 102 includes a sample collection storage 304 and an infusion solution storage 306.
- the sample collection storage 304 may include a plurality of containers (such as vials, resealable bags, etc.), and each container (e.g., vial) receives one sample of the fluid drawn from the patient during the sample collection event.
- the container may be sealed after the appropriate sample is taken to prevent the sample from being contaminated.
- the infusion solution storage 306 may include one or more types of fluid to be expelled to be used for infusion, such as drug solution or saline solution, for example, where each type of fluid is separated from each other in different containers to prevent intermixing or contamination of fluids.
- the sample collection storage 304 or the containers contained therein may be cooled or maintained at an optimal temperature (for example, using any suitable air conditioning unit or temperature control device) after collecting blood samples.
- an optimal temperature for example, using any suitable air conditioning unit or temperature control device
- Other environmental parameters such as pressure and/or humidity, for example, may also be controlled as suitable to optimize the stability of the samples.
- the different samples stored in the storage 304 during the sample collection events as well as the amounts and types of fluid being expelled from the storage 306 during the infusion events are automatically timestamped by the processing unit 200 of the controller 106 in real time as the device 102 operates, and recorded or stored in the memory unit 202 of the controller 106.
- the controller 106 may be implemented as part of the device 102 or as a separate modular device that may be disconnected from the device 102.
- the device 102 includes its own processing unit and/or memory unit separate from the controller 106, and the processing unit of the device 102 may timestamp and store the sample data in its memory unit.
- the data may be stored in a remote database connected to the device 102 via a cloud network or Internet-of-things (IoT) infrastructure.
- IoT Internet-of-things
- the device 102 includes a user input interface 308 which may be similar to or different from the interface 204 of the controller 106.
- the user input interface 308 may be one or more buttons that can be pressed by the user to begin the sample collection event or the infusion event, without having to rely on the controller 106.
- the user input interface 308 is an interactive display such as touchscreen panel.
- the user input interface 308 may have more limited and/or simplistic functionality than the interface 204 of the controller 106 so as to prevent the user from erroneously entering a different setting or starting the wrong event, thereby providing a safety mechanism against the user possibly overdosing the patient, infusing the patient with a wrong solution, or taking too many blood samples for the patient which may be unnecessary or even harmful to the patient (including but not limited to a patient who is very young or neonatal/newborn patient, a patient who has a small body type, or a patient who is prone to having anemia).
- the device 102 includes one or more alarms 310 which provide sensory or auditory alerts or notifications in response to detecting certain conditions.
- the conditions may include abnormal measurement in the blood sample, possible occlusion or air detected in the conduit 104, or the device 102 not operating as it is intended, among others.
- the conditions may include the conduit or conduits 104 being detached from the patient or any component of the device 102 (such as the pumps 300, sensors 302, storages 304 and 306, or interface 308) malfunctioning or disconnected, either physically or electrically.
- the alarms 310 may indicate a low battery status of the device 102, or the device 102 being disconnected from a power source.
- the alarm 310 may be auditory (e.g., a voice explaining the situation or a beeping sound to alert the user) and/or visual (e.g., colored alert sign when certain conditions are detected, otherwise green or yellow when a low-risk condition is detected, for example).
- auditory e.g., a voice explaining the situation or a beeping sound to alert the user
- visual e.g., colored alert sign when certain conditions are detected, otherwise green or yellow when a low-risk condition is detected, for example.
- FIG. 4 shows a process 400 which may be implemented by the controller 106 in some embodiments.
- the process 400 may be facilitated by the processing unit 200 of the controller 106 when the processing unit 200 runs a computer program code or instructions stored on the memory unit 202 or more specifically the non-transitory computer-readable medium.
- the processing unit 200 receives or detects a command to obtain a sample from or to perform infusion on the patient.
- the processing unit begins the sampling or infusion by operating the pumps of the associated sampling and infusion device such that the device collects the blood sample from the patient (in a sample collection event) and/or expels a fluid solution to the patient for infusion (in an infusion event), as suitable.
- the exact time of each event is recorded automatically (i.e., timestamped), and the sample taken during the sample collection event is associated with the specific timestamp as recorded.
- the infusion time is also recorded automatically, such that each timestamped infusion event is associated with a specific value of fluid dispelled from the device (e.g., a type of fluid, an amount or volume of the fluid, and a concentration of the fluid, etc.).
- step 406 the processing unit 200 ends the sampling or infusion by pausing or stopping the operation of the pump(s) as suitable, and the time at which the pump(s) is paused or stopped (or the time at which the sampling or infusion is ended) is also automatically recorded or timestamped as the end of the sample collection event or the infusion event, as suitable.
- the timestamp data is then stored in the memory in step 408, and the sampling or infusion event associated with the timestamp data is also linked to the timestamp in the memory.
- the timestamp may thus be automatically facilitated such that a first timestamp indicates a start time of an event and a second timestamp indicates an end time of an event.
- the timestamp may span a period of time instead of marking an instance of time, such that the beginning of a timestamp indicates the start time of the event, and the end of the timestamp indicates the end time of the event.
- FIG. 5 shows another process 500 which may be implemented by the controller 106 in some embodiments.
- the processing unit of the controller receives or detects a command to obtain a blood sample from the patient and to perform infusion on the patient, as suitable.
- the infusion is performed in an infusion event, and the exact time of the infusion event is recorded as a first timestamp.
- the first timestamp is stored in the memory, and the first timestamp is linked to the infusion event.
- FIG. 6 shows an apparatus 600 as used in the automated fluid sampling and infusion system 100 according to some embodiments.
- the apparatus 600 may be referred to as an automated fluid sampling and infusion device with different device components which can be removably attached thereto or installed therein.
- a sterile saline packet 602 provides the sterile saline solution to allow for the flushing of any catheter(s) or tube(s) that is used for fluid sampling during an interval between two different sampling events, such as the catheter/tube 702 shown in FIG. 7 , for maintenance purposes.
- the sterile saline packet 602 may be attached to or installed on one side of the apparatus 600 while a waste saline packet 604, which receives excess blood from the patient and/or the saline solution after flushing the apparatus, may be attached to or installed on the other side.
- the apparatus 600 may also receive a vial cassette 606 (which may also be referred to as a blood sample collection apparatus) which may be removably installed in the apparatus 600 and may house, hold, or contain multiple vials 608 or sample containers for sampling the bodily fluid (for example, blood) of a patient.
- Saline solution may flow from the packet 602 into the apparatus 600 to flush the catheter or tube periodically, such as into the patient's body, and any remaining fluid or particles in the apparatus may be transported into the waste saline packet 604 for easy disposal at a later time. This flushing may be repeated to reduce the risk of contamination between samples and/or to avoid the clogging up of the catheter or tube between sampling events.
- the cassette 606 makes it easier for multiple vials 608 to be installed and removed simultaneously without the risk of accidentally rearranging the order of the vials 608, as the vials 608 may be arranged such that each slot of the cassette 606 represents a specific sample taken at a specific time.
- the apparatus 600 houses the processing unit 200 and the memory unit 202 as well as providing the I/O interface 204 as shown in FIG. 2 .
- the apparatus 600 may also be referred to as the sampling/infusion device 102 as shown in FIG. 1 and thus may contain any one or more of the components as shown in FIG. 3 according to some examples.
- the apparatus 600 may maintain the samples in refrigeration by providing a casing 610 which can be closed when the samples (e.g., the cassette 606 holding the vials 608 containing the samples) are stored inside the apparatus 600.
- the cassette 606 may facilitate the refrigeration or retain the samples in a refrigerated state.
- the apparatus 600 may also have an infusion device or component integrated or incorporated therewith, or the infusion device or component may be a separate device(s) that is integrated into the overall system 100 and is operable in conjunction with the apparatus 600, in order to facilitate the infusion events in addition to the sample collection events as mentioned above.
- FIG. 7 shows another apparatus 700 as used in the automated fluid sampling and infusion system 100 according to some embodiments.
- the packets 602 and 604 are attached or hooked to the side of the apparatus 700 while fluidly coupled with the appropriate components within the apparatus 700 through catheters or tubes 702, for example.
- the saline solution from packet 602 may be used to clean the inside channel or lumen of the catheters or tubes 702 after each sample collection event.
- the apparatus 700 is designed so as to automatically maintain integrity of the catheters or tubes 702.
- the catheter or tube 702 may be multiple catheters or tubes operating independently of one another, or a single catheter or tube with multiple lumens or channels that are independently operable, for example.
- the apparatus 700 also includes a slot or holder 704 for the vials 608 to be used for collecting blood samples.
- the apparatuses 600 and 700 are designed to be programmable to serially draw blood sample(s) in a predetermined or programmed time interval or schedule and in a predetermined or programmed volume for each sample. The amount of blood to be drawn and/or the time interval may be inputted via a user interface such as the interface 204 or 308 as explained above.
- the apparatuses 600 and 700 may be battery operated and may be mobile (such as being attached to a stand with rollers to facilitate moving to different locations within a hospital or other places, as suitable).
- the apparatuses 600 and 700 may be auto-maintained (that is, maintained automatically to require minimal maintenance by the users) and may be compatible with all suitable diagnostic equipment as known in the art.
- the apparatuses 600 and 700 may be manually triggered by a caregiver or research technician (for example, in a drug clinical trial).
- a caregiver or research technician for example, in a drug clinical trial.
- there may be provision for refrigerating the collected samples such as by providing an electrically powered refrigeration system or device, which may be powered by a battery or any other suitable type of energy supply associated with the apparatus.
- the collection vials may be manually inserted and/or removed.
- the aforementioned apparatuses may be suitably modified, for example, to add or remove any one or more of the aforementioned components or capabilities, in order to reduce the cost of manufacturing the apparatuses, to reduce the overall weight or dimensions of the apparatuses, and/or to increase the energy efficiency (such as battery life and consumption) of the apparatuses.
- Refrigerating the samples assists in slowing down chemical reactions in the sample collected. Some of the chemical reactions include, but are not limited to, enzymatic reactions, decomposition of certain drugs, oxidation by dissolved oxygen, and so on. Refrigerating the samples further assists in slowing down the clotting cascade (or gradual clotting of the samples collected), and the samples that are constantly refrigerated have more time to mix with anticoagulants which may be used to coat the interior of the sampling tube (such as the conduit 104 of FIG. 1 and the catheters or tubes 702 of FIG. 7 , for example). Therefore, leaving the samples at room temperature before mixing is complete may cause the clotting process to begin.
- anticoagulants which may be used to coat the interior of the sampling tube (such as the conduit 104 of FIG. 1 and the catheters or tubes 702 of FIG. 7 , for example). Therefore, leaving the samples at room temperature before mixing is complete may cause the clotting process to begin.
- the nurse or phlebotomist may gently tip the tubes back and forth about 8-10 times after the sample is collected in order to assure that the anticoagulant is sufficiently mixed, especially when using larger tubes where the diffusion distance is greater between the dissolving anticoagulant and the freshly collected blood sample. Neglecting to tip the tubes (e.g., if the caregiver, nurse, or phlebotomist is distracted in a busy hospital environment) may cause the aforementioned clotting, thereby causing problems with the diagnostic instruments which use the collected samples for analysis. For example, the formation of such clots may distort the measured results especially in hematology instruments. Incorrect results may pose a potential threat to the safety of the patients even if the error occurs relatively infrequently.
- the additional step of the aforementioned manual "mixing by tipping" may not be reasonably feasible when a series of samples are to be collected based on a predetermined schedule over several hours. Furthermore, handling the sampling tube too aggressively (for example by manually pulling against the tube) may cause the samples to experience hemolysis, which may necessitate resampling to maintain the integrity of the analysis of the samples, causing further delay in providing critical data for the patient. As such, it is beneficial to constantly refrigerate the samples after collection.
- FIGs. 8A through 8C show different steps in a fluid-drawing process as implemented by the apparatus 700.
- an empty vial 608 is placed (e.g., downwardly as indicated by the arrow) on the holder 704 while the holder 704 is located externally.
- the holder 704 holding the empty vial 608 is inserted into the apparatus 700 as shown by the inwardly pointing arrow for fluid sample collecting (or any other type of bodily fluid, as appropriate).
- FIG. 8C the holder 704 returns to the initial state as in FIG.
- the vial 608 is now filled with a predetermined or programmed amount of blood sample to be retrieved from the holder 704 (e.g., upwardly as indicated by the arrow) to be replaced with a new empty vial 608 to repeat the process for collecting multiple samples.
- the vials 608 may be of any suitable size and shape, and in some cases multiple vial formats may be implemented to distinguish between different types of samples.
- Each vial 608 may only contain a single sample obtained during a single sample collection event.
- the sample collection may be automatic, such that the insertion of the holder 704 into the apparatus 700 may be sufficient to trigger the sample collection.
- the sample collection is manually activated, such as by pressing a button to collect a sample of a predetermined or programmed amount.
- the system 100 facilitates automated blood drawing such that the number of blood-draws required can be preprogrammed, and the amount of blood that is drawn can be small, such as less than 0.1 cc, less than 0.05 cc, less than 0.04 cc, less than 0.03 cc, less than 0.02 cc, or any other suitable range or value therebetween.
- the amount of each sample may be less than a drop, e.g., less than 0.025 cc and even as low as 0.01 cc (or 10 ⁇ L).
- the amount may range to several cc, for example up to 1 cc, up to 5 cc, up to 10 cc, or any other suitable range or value therebetween, as preprogrammed by the user. Because all the values are programmed, the system 100 has high precision regarding the volume and timing of each sampling, such as by precisely controlling the sampling amount and the sampling interval.
- the precision in time and allowing the volume of sample collecting to be small may be important for patients who may not be physically capable of providing a high volume of bodily fluid such as blood for sampling.
- pediatric venipuncture volumes is a topic of constant discussion because the amount of blood that can be safely removed from a child may vary depending on the size and age of the child, such as a newborn.
- the guidelines as set forth in CLSI GP41-Ed7 indicate that, assuming 75-80 mL/kg blood volume in children (or higher in newborns), blood collection from a child should be limited to 1-5% of total blood volume over 24 hours and also to 10% total blood volume over 8 weeks.
- the European Commission Guideline indicates that, assuming 80-90 mL/kg blood volume in children, the recommended blood collection volume from a child should be limited to 1% of total blood volume over 24 hours and also to 3% total blood volume over 4 weeks, although the guideline indicates that the recommendations are not evidence-based.
- Other institutions may have different values as part of the guidelines implemented in the institutions, so it is difficult to determine the upper threshold levels of how much blood may be safely collected from children.
- there is generally reluctance to draw blood from young children so if the samples are collected manually, such samples may be collected less frequently such as only once a day or once a week, thereby resulting in insufficient number of samples for proper analysis.
- the system 100 benefits from automated blood sample collecting by minimizing the sample volume and maintaining a predetermined or preprogrammed sampling frequency so as to make it easier for doctors and physicians to determine a pattern or trend in the collected blood samples in order to make their diagnosis or to monitor the prognosis.
- a doctor or nurse may determine the patient's health condition based on the collected sample data and/or sensor measurements from a previous cycle, or from additional/external devices that are operatively coupled with the processing unit. For example, the doctor or nurse may analyze using the appropriate sensor measurements whether the patient is suffering any medical condition that may require immediate medical attention or a change in the infusion dosage. Based on the determined condition, the doctor or nurse may determine the dosage of infusion accordingly to be implemented in the infusion step 504 (e.g., type, amount/volume, and/or concentration of the drug for infusion).
- the processing unit may recommend a dosage of the infusion fluid in the next or subsequent infusion event based on a result of an analysis performed by the sensors on the collected sample, such as a CBC test, which may be accepted or rejected by the doctor or nurse.
- the infusion is facilitated by the processing unit by controlling the pumps to limit the dosage of infusion to the dosage determined by the doctor or nurse.
- the exact time of the infusion (for example, beginning and ending times of the infusion event) is automatically recorded and timestamped as the first timestamp, as are the information pertaining to the dosage given during this event.
- the determined dosage may include the specific amount or volume of the solution to be used for infusion, as well as the concentration of the solution that is being used.
- the pumps may operate such that at least one pump is connected to the infusion solution storage of the infusion device and at least one pump is connected to a different storage which stores a solution used to dilute the infusion solution provided by the infusion solution storage. That is, when the concentration of the infusion fluid is to be reduced, the pump connected to the diluting solution may be activated as suitable to dilute the infusion fluid by mixing the diluting solution with the infusion fluid.
- the processing unit may operate the pumps (for example, the sampling pump) to perform sampling, such that predetermined amount or volume of the patient's blood can be collected as a sample at a predetermined time, and subsequently stored.
- the time of the sampling event is recorded (timestamped) automatically.
- a second timestamp for the sampling event is linked to the data associated with the collected sample and stored in the memory unit. The process 500 may be restarted when another command is detected for the next sample collection event and infusion event.
- the timestamped data is organized in a table (for example, a pivot table or lookup table) or an illustrated chart for visibility when the users access and review the data, which may facilitate improved decision making by the doctors or nurses.
- the command may be provided as a set of timed instructions (e.g., each of the sample collection events and infusion events have a specified time or margin of time in which they must be performed) or as a manual user input such as when a button is pressed or actuated.
- the sample collection and infusion device is a smart device which is capable of communicating with other devices such as smartphones or computers, as well as with other similar devices as suitable, such as in an loT setting.
- the smart device which includes its own processor and memory, may store in its memory (e.g., memory unit 202) a drug library which is a list of drugs which is used as reference by the processor of the smart device in order to prevent medication errors.
- the drug library may include protocols or instructions for commonly infused drugs that define the flow rate and total volume reflecting the mass of drug (for example, in mg) to be dosed over a defined time (for example, in seconds or minutes).
- AUC area under the curve
- concentration data available, the exposure to the drug can be adjusted in subsequent infusions.
- concentration data available, the efficacy may be inadequate.
- concentration is too low, that is, below the minimum inhibitory concentration (MIC) for the invading microbe, the efficacy may be inadequate.
- concentration is too high, the patient may be subject to toxicity in specific organs such as the kidneys, liver, or heart, etc. Clearance (and thus concentration and AUC) varies with patient size, age, gender, types of co-administered drugs, and organ function capabilities (including, but not limited to, kidney and liver function, for example).
- Such data may be used to determine a dose recommendation in the prescribing information provided by the drug manufacturer and approved by the Food and Drug Administration (FDA).
- FDA Food and Drug Administration
- a mathematical model of the pharmacokinetics may also provide the expectations for clearance and AUC.
- the dynamics for the average patient may suggest a specific post-dose blood sampling protocol sequence. In some embodiments, a few points (for example, between 3 to 5 points) of blood sampling at specific times may sufficiently enable dose adjustment for the individual patient.
- Such schedule may vary from one drug to another and may be programmed into the controller 106 to facilitate the automatic blood sampling and infusion, or more specifically, programmed into the drug library which the controller 106 utilizes.
- the drug library may include protocols or instructions on the sample collection event and the infusion event associated with each of a plurality of drugs administered during the infusion event.
- protocol may be programmed flexibly via an external port to a network, such as via the network connection 108, using the additional device(s) 206.
- each drug may set one or more parameters such as concentration, infusion rate, and dosage thresholds (maximum and minimum), and the doctor or nurse may be required to confirm the correct drug and dosage to implement for each patient (if there are multiple patients) manually via the aforementioned user interface.
- concentration, infusion rate, and dosage thresholds maximum and minimum
- dosage thresholds there are different levels of dosage thresholds.
- a first level is a preferred dosage amount or dosage range which the doctor or nurse may exceed under certain circumstances.
- a second level may be an absolute dosage limit which may never be exceeded under any circumstance, since doing so increases the risk of the patient undergoing complications from the drug.
- the different levels of dosage thresholds may be determined in view of the combination of drugs that are to be delivered.
- the different levels of dosage thresholds may be determined using the patient's physical data such as age, weight, gender, etc. In some examples, the different levels of dosage thresholds may also be determined by the smart device using the patient's past or historical data such as medical history. In some examples, the smart device may retrieve such data from an external database via the network connection.
- the smart device may intercept errors such as incorrect dosage rate, dosage amount, and/or pump settings.
- Other benefits include reducing the chances of adverse drug events (e.g., overdose or underdose), improving the doctors and nurses' practice, and increasing the cost effectiveness of the system.
- the smart device may be capable of approximating and subsequently adjusting drug dosage such as the dosage rate, dosage amount, and/or pump settings based on sensor measurement during clinical trials or clinical applications/treatments.
- initial drug dosage parameters (which may be defined as including any one or more of the dosage rate, dosage amount, and/or pump setting for the particular drug) may be established based on the patient's size (height and/or weight), age, gender, body mass index (BMI), and any applicable preexisting condition such as those indicated in the medical record.
- the drug dose parameters are determined and stored as a first approximation, for example in the memory unit of the device.
- the drug concentration within the patient's body varies with time.
- the smart device may take one or more sample measurements of the blood volume or rate of clearance (using any sensor suitable for such purpose) and calculate subsequent drug dosage parameters based on such measurements. For example, after taking such measurements, the device may calculate the next dosage parameters by adjusting the previously stored dosage parameters based on the measurements. That is, a second set of dosage parameters may be determined by adjusting the initial (first set of) dosage parameters, and a third set of dosage parameters may be determined by adjusting the second set of dosage parameters.
- the approximation of the dosage parameters will be more precise than before, thereby providing a process of calculating the best dosage parameters that are suitable for the patient, or patient-specific, taking into account different factors such as the variations in drug absorption and excretion (related to metabolism, transporters, and organ function integrated over time) and/or the qualitative and quantitative variations in drug target (receptor) expressions, for example.
- the initial dosage parameters may be set at low threshold values, and the adjustments gradually increase the parameter values to reach the best dosage parameters.
- the adjustment may be based on, for example, comparing the drug concentration measurement with a threshold concentration value (which may be predetermined or learned via machine learning using tens, hundreds, or thousands of datapoints, as known in the art) or using a lookup table pertaining to the specific type or class of drug that is administered, as stored in the memory unit.
- a threshold concentration value which may be predetermined or learned via machine learning using tens, hundreds, or thousands of datapoints, as known in the art
- a lookup table pertaining to the specific type or class of drug that is administered, as stored in the memory unit.
- the drugs may be grouped or categorized in the system based on what "type" they are associated with. Some of the types of drugs which may be used for this purpose may include, but are not limited to: immunosuppressants, antibiotics, anticoagulants, insulins, chemotherapeutics, and so on. Each type has its own threshold or region of efficacy as well as its threshold or region of safety. For example, immunosuppressants may lead to organ rejection if the dosage is too low, but toxicity or infections may take over if the dosage is too high. Antibiotics may not be capable of inhibiting bacterial growth if the dosage is too low, but they may be toxic if the dosage is too high.
- Insulins may cause hyperglycemia if the dosage is too low, but they may cause hypoglycemia if the dosage is too high.
- Chemotherapeutics may fail to rid the body of cancer cells if the dosage is too low, but they may destroy other healthy cells as well if the dosage is too high.
- the automated blood sampling and infusion system as disclosed herein facilitates reduction of such risks by providing an automated and accurate time management for both dose administration (for example, with a smart device controlling the infusion pump) and blood sampling (as an illustrative example, as few as 3 samples or as many as 12 samples, or any other sample number therebetween, obtained within 6 hours after infusion at precisely-measured time increments), as well as an automated and accurate dosage management based on sampling a small volume of blood and measuring the drug concentration therein.
- the small volume sample (for example, between 0.1 mL and 0.5 mL, between 0.5 mL and 1.5 mL, between 1.5 mL and 2.5 mL, or any other suitable value or range therebetween) facilitates more frequent drug concentration measurement to take place, as well as reducing the burden on the patient of drawing a large quantity of blood for sampling.
- the smart device may implement processes (which may be performed by algorithms such as computer program codes stored in the memory unit and run by the processor, for example) to adjust the dosage parameters and "learn" from real-world experience beyond the clinical trials.
- the sensors are capable of sensing or measuring at least one of: blood temperature, blood pressure, pulse (heart rate), or breathing rate (respiratory rate).
- the sensors can measure the amount or level of gases in the patient's blood. These measurements can be accurately plotted along a time axis. Other measurements include flow rate of the fluid (for sampling and/or infusion), volume of the fluid being transported via the conduits (for sampling and/or infusion), concentration of the fluid (mainly for infusion), etc.
- Allowing the system to automatically perform blood sampling and infusion can also avoid wasting blood that is collected (for example, when blood collected at a wrong time interval would be less useful and the sample may need to be redrawn or collected again), avoid anemia caused by oversampling blood by hand, avoid hemolysis caused by a too aggressive manual pull on a catheter, avoid dilution of the blood sample by inadequate clearing of lock solution from the catheter before sample collection, and/or reduce the risk of infection (e.g., as caused by blood-borne pathogens) resulting from conventional blood sampling procedures performed by hand.
- the catheter patency may be automated such that any obstruction in the catheter is avoided or detected by the sensors.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Primary Health Care (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202263389159P | 2022-07-14 | 2022-07-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4306049A1 true EP4306049A1 (fr) | 2024-01-17 |
Family
ID=87245432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP23184859.9A Pending EP4306049A1 (fr) | 2022-07-14 | 2023-07-11 | Dispositif de surveillance automatique de perfusion de médicament avec échantillons temporisés |
Country Status (3)
Country | Link |
---|---|
US (1) | US20240016998A1 (fr) |
EP (1) | EP4306049A1 (fr) |
JP (1) | JP2024012156A (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060189926A1 (en) * | 2005-02-14 | 2006-08-24 | Hall W D | Apparatus and methods for analyzing body fluid samples |
US20090069743A1 (en) * | 2007-09-11 | 2009-03-12 | Baxter International Inc. | Infusion therapy sensor system |
US20100121170A1 (en) * | 2008-09-12 | 2010-05-13 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US20100273738A1 (en) * | 2009-04-23 | 2010-10-28 | Valcke Christian P | Integrated patient management and control system for medication delivery |
US20110313318A1 (en) * | 2010-06-17 | 2011-12-22 | Optiscan Biomedical Corporation | Systems and methods to reduce fluid contamination |
-
2023
- 2023-07-11 EP EP23184859.9A patent/EP4306049A1/fr active Pending
- 2023-07-12 JP JP2023114314A patent/JP2024012156A/ja active Pending
- 2023-07-14 US US18/222,059 patent/US20240016998A1/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060189926A1 (en) * | 2005-02-14 | 2006-08-24 | Hall W D | Apparatus and methods for analyzing body fluid samples |
US20090069743A1 (en) * | 2007-09-11 | 2009-03-12 | Baxter International Inc. | Infusion therapy sensor system |
US20100121170A1 (en) * | 2008-09-12 | 2010-05-13 | Optiscan Biomedical Corporation | Fluid component analysis system and method for glucose monitoring and control |
US20100273738A1 (en) * | 2009-04-23 | 2010-10-28 | Valcke Christian P | Integrated patient management and control system for medication delivery |
US20110313318A1 (en) * | 2010-06-17 | 2011-12-22 | Optiscan Biomedical Corporation | Systems and methods to reduce fluid contamination |
Also Published As
Publication number | Publication date |
---|---|
US20240016998A1 (en) | 2024-01-18 |
JP2024012156A (ja) | 2024-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112119467B (zh) | 医疗装置数据反向关联、系统、设备和方法 | |
US20180261322A1 (en) | Smart syringe: monitoring medical intervention information | |
US20190336678A1 (en) | Method and apparatus for analyte measurement, display, and annotation | |
ES2799305T3 (es) | Adaptador inteligente para dispositivos de infusión | |
EP2356604B1 (fr) | Système d'acquisition, de gestion et d'analyse de données de patient sous hémodialyse | |
US20190282141A1 (en) | Fluid analyte detection systems and methods | |
US20060229531A1 (en) | Blood monitoring system | |
US20090156922A1 (en) | Blood monitoring system | |
US20090264720A1 (en) | Wearable Automated Blood Sampling and Monitoring System | |
US9592002B2 (en) | Method and system to derive multiple glycemic patterns from glucose measurements during time of the day | |
US20170067846A1 (en) | Method and system to derive glycemic patterns from clustering of glucose data | |
US20130085471A1 (en) | System and Method for Monitoring Time Intervals During Blood Parameter Monitoring | |
WO2010124127A1 (fr) | Système intégré de gestion et de contrôle de patient pour l'administration de médicaments | |
JP2008515483A (ja) | 血液監視システム | |
TW201535305A (zh) | 以葡萄糖監控器與輸入幫浦來提供快速給藥上之反饋的糖尿病管理方法及系統 | |
EP4306049A1 (fr) | Dispositif de surveillance automatique de perfusion de médicament avec échantillons temporisés | |
US20220143316A1 (en) | System with a device and a process for controlling an administration of a drug to a patient | |
WO2011031351A1 (fr) | Système d'analyse de composants liquides et méthode de surveillance et de contrôle du glucose | |
US20200038587A1 (en) | Systems and methods for monitoring and controlling a state of a subject during volume resuscitation | |
WO2023150737A1 (fr) | Techniques de détermination de facteurs de correction de médicaments dans des systèmes d'administration automatique de médicaments | |
CN116456898A (zh) | 用于区分预注笔事件和治疗笔事件的药物注射笔 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20240416 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |